Background: Genetic studies of Saccharomyces cerevisiae have shown that Snf1p and Snf4p, which together form the SNF1 complex, are essential for gene derepression on removal of glucose from the medium. However the metabolic signal(s) involved, and the exact role of SNF1, have remained enigmatic. Recently, the AMP-activated protein kinase (AMPK) was shown to be the mammalian homologue of SNF1. AMPK is activated by the elevation of the cellular AMP:ATP ratio, which occurs during cellular stress in mammalian cells. The mechanism of activation involves phosphorylation of AMPK by an upstream protein kinase (AMPKK). We have investigated whether a similar mechanism might explain the role of SNF1 in yeast in the response to the stress of glucose starvation.
Background
Glucose repression (catabolite repression) is the phenomenon whereby high levels of glucose repress the expression of specific genes. In Saccharomyces cerevisiae, glucoserepressed genes include those required for oxidative metabolism, and for metabolism of alternative carbon sources, such as sucrose, maltose and galactose [1, 2] . The SNF1 gene (also known as CCR1 or CAT1) is essential for derepression of these genes [3] [4] [5] , and sequencing and expression studies have revealed that SNF1 encodes a protein kinase [6] . SNF1 homologues have been cloned from higher plants; these rescue snf1 mutations in yeast [7, 8] , suggesting that this gene family is of wide relevance to the regulation of gene expression in eukaryotes.
Mutations in the yeast SNF4 (CAT3 [9] ) gene have essentially the same phenotype as those in SNF1, and functional SNF4 is essential for the protein kinase activity of Snf1p [10, 11] . Snf1p and Snf4p form a complex in vitro and in vivo [12] [13] [14] . In this paper, we use the term SNF1 to refer to the minimal complex comprising Snf1p and Snf4p. Carlson's group have also defined three other genes (SIP1, SIP2 and GAL83) whose products interact with Snf1p via a conserved carboxy-terminal region (the ASC domain) [15] . Although not essential for derepression, these are proposed to be 'adaptor' or 'targeting' subunits which direct the SNF1 complex to specific downstream targets.
The mammalian homologue of SNF1 is the AMP-activated protein kinase (AMPK) [16, 17] , which phosphorylates a number of targets in vitro and in vivo [18] . A current hypothesis for the function of the AMPK system is that it acts as a cellular 'fuel gauge', switching off non-essential pathways in response to environmental stresses which deplete ATP [19] . Depletion of ATP causes elevation of the AMP:ATP ratio by displacement of the adenylate kinase reaction, and this activates AMPK via direct allosteric activation [20, 21] and by multiple mechanisms which promote phosphorylation of AMPK by an upstream protein kinase, AMPK kinase (AMPKK) [22, 23] . AMPK is a 1:1:1 complex formed from a catalytic ␣ subunit and noncatalytic ␤ and ␥ subunits (formerly p63, p38 and p35) [24] . Cloning and sequencing of cDNAs encoding these subunits revealed a close similarity between AMPK-␣ and Snf1p, AMPK-␥ and Snf4p, and AMPK-␤ and the ASC domains of Sip1p, Sip2p and Gal83p [17, [25] [26] [27] . Thus, the The metabolic signal(s) which trigger glucose repression/ derepression in S. cerevisiae, or indeed in any eukaryote, remain enigmatic [2] . The mechanism by which SNF1 mediates derepression is also unclear. By contrast, both the metabolic signal and the mechanism by which AMPK is activated in response to environmental stress in mammalian cells are well understood [18] . High ratios of AMP:ATP activate the system in part through direct allosteric activation of AMPK, but also by stimulating phosphorylation and activation of AMPK by AMPKK. The high degree of sequence similarity between the AMPK and SNF1 complexes suggested that SNF1 might be activated by phosphorylation in response to glucose starvation, and that AMP might be a signal involved in this event.
Results

Assay of SNF1 protein kinase in yeast extracts
In order to assay SNF1 activity in a crude yeast extracts, we measured the phosphorylation of the 'SAMS' peptide (HMRSAMSGLHLVKRR; single-letter amino-acid code), which was developed originally for the assay of mammalian AMPK [30] . If cells were harvested under derepressing conditions, the activity in the wild-type strain MCY1094 was greater than 10-fold higher than that in a snf1-disrupted strain in the same genetic background (MCY1828; Fig.1a ). This result confirmed that the SAMS peptide was a reasonably specific substrate for SNF1, although there was a low background of peptide phosphorylation in the knockout strain. Figure 1a also shows that there was a very large activation of SNF1 protein kinase in cells transferred to derepressing conditions (0.05 % glucose) compared with repressing conditions (2 % glucose). The greater than 10-fold difference between the snf1-disrupted and the wildtype strain was only seen under derepressing conditions. In cells maintained in high glucose, the apparent SNF1 activity in the wild-type was identical to the low, background activity in the knockout strain. The low basal activity in the wild-type strain is therefore likely to be due to other protein kinases which slowly phosphorylate the SAMS peptide.
In order to observe the large activation of SNF1 on transfer to derepressing conditions, the method of harvesting the cells was critical. Figure 1b shows experiments conducted with yeast strain ABYS106, which was used for subsequent purification of SNF1. The large difference in activity between repressing and derepressing conditions was observed only if cells were harvested by rapid membrane filtration and immediately frozen in liquid nitrogen. If cells were harvested in the conventional manner -by centrifugation and resuspension in homogenization medium lacking glucose -the peptide kinase activity was as high under repressing conditions as it was under derepressing conditions. The dramatic activation of SNF1 observed on transfer from repressing to derepressing conditions appears to be due to phosphorylation, because it was completely reversed by incubating the extracts with the homogeneous catalytic subunit of mammalian protein phosphatase-2A (PP2A; Fig.  1c ). This effect was prevented by the addition of the PP2A inhibitor, okadaic acid. PP2A had no significant effect on the low basal activity observed in extracts made by rapid filtration under repressing conditions.
Purification and properties of SNF1 protein kinase
The SNF1 complex was purified by a modification of the method of Mitchelhill et al. [16] , which exploits the ability of a polyhistidine stretch near the amino terminus of Snf1p to bind to Ni 2+ -Sepharose. Peptide kinase activity was 'SAMS' peptide kinase activity measured in yeast extracts. (a) Activity in a snf1-disrupted strain (MCY1828 snf1-⌬10) compared with a wildtype with the same genetic background (MCY1094). (b) activity in extracts of strain ABYS106 harvested by rapid filtration and freezing ('filtration'; see Materials and methods), or by centrifugation (2000 × g, 2 min) followed by resuspension in homogenization buffer and immediate homogenization ('centrifugation'). (c) Cells of strain ABYS106 were harvested by rapid filtration, extracts prepared, and the extracts were incubated at 30°C for 10 min with mammalian protein phosphatase-2A (PP2A; 10 U ml -1 ) either in the presence or absence of 100 nM okadaic acid (OA). In all three experiments, extracts were derived from cells in mid-log phase which had been maintained in 2 % glucose, harvested by centrifugation, then incubated for a further 15 min in medium containing either 2 % or 0.05 % glucose. purified 5700-fold with a final specific activity of 1.21 mol min -1 mg -1 . Fractions from the leading edge of the kinase peak from the Ni 2+ -Sepharose column were not pure, but silver staining of fractions from the trailing edge detected only two polypeptides, of 72 and 36 kDa, which cross-reacted on blots with antibodies directed against Snf1p and Snf4p, respectively (data not shown). There was no evidence for stoichiometric quantities of a third subunit, corresponding to Sip1p, Sip2p or Gal83p, although it is possible that these are not readily detectable by silver staining.
Concentrations of AMP up to 200 M had no effect on the peptide kinase activity of purified SNF1. A wide range of sugar phosphates, including glucose-6-phosphate, 2-deoxyglucose-6-phosphate, glucose-1-phosphate, glucose-1,6-bisphosphate, fructose-6-phosphate, fructose-1,6-bisphosphate, fructose-2,6-bisphosphate, dihydroxyacetone phosphate, xylulose-5-phosphate and ribulose-5-phosphate, were also without effect at concentrations up to 8 mM.
Regulation of SNF1 by reversible phosphorylation
Although we could find no evidence for allosteric regulation, purified SNF1 was inactivated in a time-dependent manner by incubation with the homogeneous catalytic subunits of mammalian protein phosphatases-1, -2A or -2C (PP1, PP2A or PP2C). As expected, inactivation by PP1 or PP2A was blocked by 100 nM okadaic acid, and inactivation by PP2C was dependent on the presence of Mg 2+ (data not shown). Purified SNF1 inactivated by PP2A treatment did not reactivate on the addition of MgATP, either in the presence or absence of AMP. However, a time-dependent reactivation was observed when MgATP plus partially purified mammalian AMPKK were added, in a reaction that was stimulated by 100 M AMP (Fig. 2a ). Unfortunately, a high level of background phosphorylation in the AMPKK preparation prevented confirmation that this was associated with phosphorylation of Snf1p.
The results in Figure 2a show that homogeneous SNF1 kinase did not reactivate after dephosphorylation when MgATP alone was added (such reactivation would indicate an autophosphorylation reaction). By contrast, SNF1 purified from derepressed cells only as far as the DEAESepharose step could be reactivated after dephosphorylation on addition of MgATP alone (Fig. 2b) . We attempted to study the effects of AMP in this crude reactivation assay, but analysis of nucleotide levels at the end of the incubations indicated that substantial quantities of AMP were being generated even when it had not been added (data not shown). The same range of sugar phosphates tested as allosteric activators of SNF1 (see above) were also without effect in this reactivation assay. SNF1 partially purified in the same way from repressed cells would not reactivate in the presence of MgATP (Fig. 2b) .
Further studies on the regulation of SNF1 kinase activity in vivo
As described above, when glucose was removed from the medium, the protein kinase activity of SNF1 was converted from an inactive to an active state by phosphorylation. This activation of SNF1 was extremely rapid, being essentially maximal in the minimum time (5 minutes) required for cell harvesting, and persisting for up to 60 minutes (Fig. 3a) . When high glucose was added back to cells that had been transiently starved for glucose, activation of SNF1 was reversed completely within 5 minutes (data not shown). Figure 4a shows the dependence of SNF1 activity on the glucose concentration in the medium. The activation of SNF1 upon glucose removal is analogous to the rapid activation of its mammalian homologue, AMPK, which occurs in response to changes in AMP and ATP in cells subjected to heat stress or chemical stress [19] . We therefore investigated whether glucose removal from the medium was associated with changes in adenine nucleotide levels. Figure 5 shows an analysis, by high performance liquid chromatography (HPLC), of perchloric acid extracts of cells that had been resuspended in medium with high (2 %) or low (0.05 %) levels of glucose and further incubated for 15 minutes. Because of slight variation in the absolute recovery of nucleotides between replicates, we found it more reproducible to express the results as ratios. In control cells maintained in high glucose, there was a high ratio of ATP:ADP (5.3 ± 0.8; n = 13), and AMP was very low (ATP:AMP: 23 ± 3; n = 13). However in cells incubated in low glucose for 15 minutes, the ADP:ATP ratio had increased 18 ± 4-fold (n = 3), and the AMP:ATP had increased 220 ± 19-fold (n = 3).
The correlation between these nucleotide ratios and SNF1 activity was examined in two experimental protocols -a time course after readdition of 2 % glucose, and a concentration dependence after readdition of glucose for 15 minutes (Figs 3,4) . When high glucose levels were added back to cells which had been transiently starved in 0.05 % glucose, both the activation of SNF1 kinase activity and the increase in the AMP:ATP and ADP:ATP ratios were essentially complete by 5 minutes, which was the minimum time required for cell harvesting (Fig. 3) . These parameters also varied over the same range of glucose concentrations (0-60 mM), although the effect on the AMP:ATP and ADP:ATP ratios was half-maximal at a slightly lower medium glucose (approximately 15 mM) than the effect on kinase activity (approximately 30 mM) (Fig. 4) . SNF1 activity and nucleotide ratios also correlated under other conditions (data not shown): for example, when glucose was replaced by sucrose (the rise in both parameters was transient due to derepression of invertase, which allows eventual conversion of sucrose to glucose), and when cells harvested by centrifugation or rapid filtration were compared (see Fig. 1b ).
Discussion
At least four novel and potentially important observations have emerged from this study. First, the protein kinase activity of SNF1 can be measured in crude yeast extracts using the SAMS peptide, although the method of cell harvesting is critical if the state of activation of the kinase is to be preserved. Second, the protein kinase activity of SNF1 is increased rapidly and dramatically by the removal of glucose from the medium, and this is due to phosphorylation, most likely of Snf1p itself. Third, a SNF1-reactivating factor (SRF) exists in yeast: as it reverses the effect of dephosphorylation and can be mimicked by mammalian AMPKK, it is most likely to be an upstream protein kinase. Fourth, under a variety of different growth conditions there is a correlation between the AMP:ATP ratio (and the ADP:ATP ratio) and SNF1 kinase activity in vivo, making these adenine nucleotides good candidates to be the metabolic signals that trigger derepression of glucose-repressed genes.
Unlike AMPK, homogeneous SNF1 was not activated allosterically by AMP, in agreement with previous studies using partially purified enzyme [10] . However, SNF1 does share with AMPK the ability to be inactivated by dephosphorylation (catalyzed by mammalian PP1, PP2A or PP2C) and reactivated by phosphorylation (Fig. 2) . The PP2A-inactivated form of SNF1 purified on the Ni 2+ column was not reactivated on addition of MgATP alone, but could be reactivated on addition of MgATP plus purified mammalian AMPKK. This suggests that reactivation of SNF1 in vivo may also be catalyzed by a distinct, upstream protein kinase rather than by autophosphorylation. We have reported recently that the site phosphorylated on AMPK-␣ by AMPKK is the threonine at position 172 (T172) [31] , which lies in the 'activation segment' where many other protein kinases are activated by phosphorylation [32] . The equivalent residue in Snf1p is T210, and mutation of this residue to alanine has already been shown to result in complete loss of SNF1 function in vivo [13] . These results suggest that T172 and T210 represent the activating phosphorylation sites in AMPK-␣ and Snf1p, respectively. Although SNF1 purified through the Ni 2+ -Sepharose column did not reactivate after PP2A treatment on addition of MgATP alone, but kinase purified only as far as the DEAE-Sepharose column did reactivate (Fig. 2) -suggesting that the Ni 2+ -Sepharose column removes an endogenous SRF. As SRF reverses the effect of dephosphorylation, and can be mimicked by mammalian AMPKK, it is likely to be an upstream protein kinase, although we cannot yet formally rule out the possibility that it represents a factor necessary for autophosphorylation. No evidence for a protein kinase upstream of SNF1 has yet emerged either from classical genetic screens or from two-hybrid screens.
The ability to measure not only the protein kinase activity of the SNF1 complex, but also its inactivation by dephosphorylation and reactivation by SRF, provides new assays with which to search for the unknown metabolic signal(s) that trigger glucose repression and derepression. Although purified SNF1 was not activated allosterically by AMP, in the mammalian system this nucleotide also promotes phosphorylation of AMPK by AMPKK via multiple mechanisms [22, 23] . Most, if not all, of these effects of AMP are antagonized by high concentrations of ATP, so that the key signal is the AMP:ATP ratio rather than AMP per se. These observations raise the possibility that elevation of AMP (or the AMP:ATP ratio) might also be a signal for activation of the SNF1 protein kinase cascade, but that it might operate by promoting phosphorylation, rather than by allosteric activation, of SNF1. We did study the effects of AMP on reactivation by endogenous SRF in the crude system shown in Figure 2b . However, when assays performed without AMP were analyzed to determine their nucleotide content, it was clear that substantial quantities of AMP were being generated during the assay. This is most likely due to contamination of the relatively crude fraction used by adenylate kinase, which would generate AMP (2ADP ↔ ATP + AMP) from ADP formed in the kinase or other ATPase reactions. A rigorous test of the hypothesis that AMP is an activating signal in the SNF1 system will therefore require further purification of SRF, and reconstitution of the cascade from highly purified components. The measurements of adenine nucleotides in vivo (see below) do provide circumstantial evidence for the hypothesis that increases in AMP (or in the AMP:ATP ratio) is the signal(s) that activates the SNF1 protein kinase cascade under derepressing conditions. Intriguingly, reactivation of SNF1 by SRF in the DEAE-Sepharose fraction did not occur if the extract was from cells prepared under repressing conditions (Fig. 2b) . This suggests that SRF activity is regulated by glucose availability, although the mechanism remains unclear.
Carlson's group previously found that the protein kinase activity of SNF1 was essential for its function [11] , but reported that it was not changed on transfer from repressing to derepressing conditions [6] . On the other hand, Woods et al. [10] reported that SNF1 kinase was activated by removal of glucose, although the effect was small (approximately 3-fold) and was not maximal until 90 minutes after removal of glucose. In contrast to these results, we found that SNF1 was activated maximally within 5 minutes after removal of glucose, and that the effect was greater than 10-fold (Figs 1,3) . The real effect is probably much larger than this, because the activity obtained under derepressing conditions was similar to that obtained in a snf1-knockout strain (Fig. 1) . As the effect could be completely reversed by adding PP2A to the lysate (Fig. 1c) , it appears to be due to phosphorylation, presumably of Snf1p by SRF. We believe there are two potential reasons for the apparent discrepancies between our findings and those of previous workers. First, the effect was only observed if the cells were harvested by rapid filtration and freezing; if they were harvested by centrifugation and resuspension in homogenization medium lacking glucose, as apparently used by Carlson's group [6] , SNF1 kinase was fully activated even under derepressing conditions (Fig. 1b) . This is a reflection of the rapidity with which activation occurs on glucose removal (Fig. 3) , and is reminiscent of previous findings with the rat liver homologue, AMPK, where freeze clamping is essential to preserve the in vivo phosphorylation state [33] . Woods et al. [10] used centrifugation to harvest the cells, but froze them in liquid nitrogen prior to homogenization. It is possible that this protocol partially preserved the in vivo activation state of SNF1. Second, we assayed SNF1 immediately in crude extracts, whereas the other workers first purified the kinase either by renaturation after gel electrophoresis and blotting [6] , or by DEAE-Sepharose chromatography [10] . It is possible that the effect of glucose removal on SNF1 activity is not fully preserved by these protocols.
With the cell-free preparations available to us, we were unable to obtain unequivocal evidence that AMP causes activation of the SNF1 protein kinase cascade in vitro, although there were correlations between the levels of adenine nucleotides and SNF1 activity in vivo under all conditions examined. The transfer of cells from high (2 %) to low (0.05 %) glucose caused rapid, greater than 200-fold increases in the cellular AMP:ATP ratio, and smaller rises in the ADP:ATP ratio. Correlations between AMP:ATP ratio (and ADP:ATP) and SNF1 kinase activity were also evident when the experimental variable was the glucose concentration, although the nucleotide ratios appeared to be affected by a slightly lower range of glucose concentrations than kinase activity (Fig. 4) . This is not necessarily inconsistent with our hypothesis, because with the very high nucleotide ratios observed in completely derepressed cells it seems likely that kinase activation system would be saturated.
We therefore propose as a working hypothesis that high AMP (or, by analogy with the AMPK system, a high AMP:ATP ratio) may be the signal for activation of SNF1 when glucose is removed from the medium. Previous hypotheses regarding the signal(s) for glucose repression and derepression have centred around hexokinase and glucose-6-phosphate, but we believe that our hypothesis is compatible with all previous genetic and biochemical data. Entian [34] reported that hex1 mutants, which gave constitutive expression of some glucose-repressed genes, were allelic to HXK2, which encodes the PII isoform of hexokinase. By contrast, the activity of the next enzyme in glycolysis, phosphoglucose isomerase, could be reduced 100-fold without apparent effect on glucose repression [35] ; this suggested a role for glucose-6-phosphate as a positive signal in glucose repression. However, given that S. cerevisiae grown on glucose uses glycolysis as the primary method of ATP production, a reduction of hexokinase activity would also be expected to deplete ATP and elevate the AMP:ATP ratio. In our hands, glucose-6-phosphate had no effect on SNF1 activity, or on reactivation of SNF1 by SRF. Negative results were also obtained with a wide range of other sugar phosphates which are intermediates or regulators of glycolysis, gluconeogenesis or the pentose phosphate pathway.
The other evidence for a role for hexose phosphates in glucose repression is that analogues of glucose such as 2-deoxyglucose [36] and 3-O-methylglucose [37] can mimic the repressive effects of glucose. These compounds are phosphorylated by hexokinases to the corresponding 6-phosphates, but are not metabolized further by glycolysis, and the results were taken as evidence that metabolism beyond hexose phosphates was not necessary to generate the glucose repression signal. A potential problem with this interpretation is that intracellular phosphorylation of these analogues rapidly depletes cellular ATP. We found that, even in the presence of 2 % glucose, 2-deoxyglucose caused a 67 % decline in ATP at 1 mM and 97 % at 40 mM (data not shown; Witt et al. [36] used 15-180 mM). In cells briefly starved of glucose (where there were already 260-and 40-fold rises in AMP:ATP and ADP:ATP), the readdition of 50 mM 2-deoxyglucose caused these ratios to rise even further (9-fold and 3-fold respectively). We therefore believe that the results with 'non-metabolizable' analogues of glucose are a reflection of the toxicity of these compounds, which may reduce cellular ATP to such low levels that it can no longer support the protein kinase activity of SNF1 and/or SRF.
Conclusions
Our current working hypothesis for the mechanism of repression and derepression of genes in S. cerevisiae in response to the availability of glucose is summarized in Figure 6 . Rapid fermentation produces a high ATP:ADP ratio, and this displaces the adenylate kinase reaction (2ADP ↔ ATP + AMP) towards ADP, maintaining AMP at a low level. The prevailing low ratio of AMP:ATP does not promote phosphorylation of Snf1p by the SRF, and protein phosphatase(s) (as yet unidentified) maintain the SNF1 complex in its inactive, dephosphorylated form. When glucose is removed from the medium, or glucose is replaced by an alternative carbon source such as sucrose, fermentation ceases due to lack of an immediately metabolizable carbon source, and a continuation of ATP-consuming pathways results in a rapid drop in the ATP:ADP ratio. The adenylate kinase reaction is now displaced in the direction of AMP formation, and there is an abrupt rise in the AMP:ATP ratio. This promotes phosphorylation of Snf1p by SRF, dramatically increasing the protein kinase activity of the SNF1 complex.
The model shown in Figure 6 also depicts possible events downstream of SNF1, based on the work of others. A number of genes acting downstream of SNF1 have been identified [2] . Many appear to encode general transcription factors which are also involved in expression of genes not controlled by glucose. A notable exception is the MIG1 gene, which encodes a Cys-His zinc finger DNA-binding protein that appears to bind specifically to promoters of glucose-regulated genes [38] . There is evidence that Mig1p is phosphorylated under derepressing conditions [39] , and an attractive hypothesis is that it is phosphorylated directly by the activated SNF1 complex. This may prevent interaction with the co-repressors Ssn6p/Tup1p and convert the repressor complex into an activator [39] .
The evidence that elevation of AMP (or the AMP/ATP ratio) is the signal which triggers derepression is currently only circumstantial. However, given the close similarity between the yeast SNF1 and the mammalian AMPactivated protein kinase systems, we regard adenine nucleotides as prime candidates to be these signals. Although certain aspects of our model are speculative, they are readily amenable to further experimental testing.
Materials and methods
Materials
Biochemicals were from Boehringer, Sigma, or Calbiochem-Novabiochem. All other reagents were analytical reagent grade from Merck-BDH. The SAMS peptide (HMRSAMSGLHLVKRR) was synthesized as described previously [30] . PP1 (human ␥ catalytic subunit expressed in E. coli [40] ), PP2A (catalytic subunit purified from bovine heart using a procedure described for rabbit muscle [41] ) and PP2C (human ␣ isoform expressed in E. coli [23] ) were gifts from Robert MacKintosh (PP1, PP2A) and Nicholas Helps (PP2C). AMPKK was purified from rat liver as far as the Q Sepharose step [31] .
Yeast strains, media, and culture
The following yeast strains were used and, unless stated otherwise, were gifts from Michael Stark: ABYS106 (mating type unknown) pra1-1 prb1-1 prc1-1 cps1-3 For routine growth at 28°C, YP medium (1 % (by mass) yeast extract, 2 % (by mass) bactopeptone) was supplemented with glucose as indicated in the text. Cells were normally grown to a density of 10 7 cells ml -1 . Small cultures (200 ml) were grown in 1 l conical flasks in an orbital shaker at 250 rpm. Large-scale cultures (25 l) were grown in a 28 l New Brunswick pilot plant. The chamber was stirred at 250 rpm and air provided at 6.5 l min -1 . The culture was concentrated to ∼1 l using a Millipore Pellicon concentration device with a 0.45 m filter. For both large-and small-scale cultures the cells were finally harvested by centrifugation (1000 × g, 10 min), washed once by resuspension in homogenization buffer and recentrifugation, and resuspended to 1 g ml -1 in the same buffer. In experiments where the carbon source was removed or exchanged, cells were transferred to sterile tubes, centrifuged (2000 × g, 2 min), resuspended in the new medium, recentrifuged, and resuspended in the medium again.
Enzyme assays
SNF1 kinase was assayed as described for AMPK but without AMP [30] . Protein phosphatases were assayed as described [41, 42] . Units of kinase/phosphatase are nmol phosphate transferred per min at 30°C. AMP-activated protein kinase kinase (AMPKK) was assayed as described [31] .
Preparation of small scale yeast extracts
Cells (∼10 7 ml -1 ) were collected by rapid filtration on nylon-66 filters (0.45 m pore size) and the cell cake scraped off and immediately frozen in liquid nitrogen. Homogenization was carried out by transferring the cell cake to a 1.5 ml microcentrifuge tube containing 300 l glass beads (acid-washed, 0.4 mm) and 150 l of 50 mM Na Hepes, pH 7.0, 50 mM NaF, 50 mM NaCl, 1 mM EDTA, 10 % (by vol) glycerol, 1 mM dithiothreitol, 1 mM benzamidine, 5 g ml -1 soybean trypsin inhibitor and 1 mM phenylmethane sulphonyl fluoride (PMSF). The mixture was vortexed 5 times for 30 sec, with 2 min on ice between each mixing. Subsequent steps were performed at 4°C. A small hole was punched in the base of the tube, which was placed inside another tube and spun in a bench centrifuge (1000 × g, 1 min) to remove the glass beads. Cell debris was removed in a microcentrifuge (14 000 × g, 1 min) and the supernatant used for SNF1 assays.
Purification of SNF1
Yeast cells (∼40 g), frozen in homogenization buffer (50 mM Tris-HCl, pH 8.4 at 4°C, 2 M NaCl, 50 mM NaF, 5 mM Na pyrophosphate, 1 mM EGTA, 1 mM EDTA and 1 mM dithiothreitol) were thawed and protease inhibitors (benzamidine (1 mM), soybean trypsin inhibitor (5 g ml -1 ), PMSF (1 mM) and leupeptin (3 g ml -1 )) plus dithiothreitol (1 mM) and antifoam A concentrate (0.02 % by volume) were added to the indicated final concentrations. Aliquots (≈ 30 ml) were homogenized with an equal volume of 0.4 mm acid-washed glass beads in a Braun mill with liquid CO 2 cooling for 1 min at 4000 rpm. The beads were allowed to settle, the extract decanted, the beads washed with 5 volumes of homogenizing buffer and the wash combined with the extract. SNF1 was purified essentially as described by Mitchelhill [16] , concentrated by centrifugation through a Centricon-30 filter (Amicon), made 30 % (by volume) with ethanediol and stored at -20°C.
Other analytical procedures and expression of results
For nucleotide analysis, cells (∼4 × 10 8 ) were collected by rapid filtration and immediately scraped into a microcentrifuge tube containing 600l of 5 % (by mass) ice-cold HClO 4 and 600 l of 0.4 mm glass beads. After vigorous vortex mixing for 30 sec, the glass beads were removed as described above, and nucleotides analysed by HPLC as described previously [19] . Determination of protein concentration [43] , PAGE, silver staining and western blotting were by standard methods. Where quantitative results are expressed in the text, they are means ± standard errors of the mean, with the number of experiments in parentheses.
Dephosphorylation and reactivation of SNF1
SNF1 was purified as above except that NaF in the Ni 2+ -Sepharose buffer was replaced by NaCl, and the kinase was diluted to ∼10 units ml -1 in 50 mM Na Hepes, pH 7.0, 0.1 % (by volume) Triton X-100, 1 mM dithiothreitol. It was incubated with PP1, PP2A or PP2C at 30°C, and aliquots were removed at intervals and diluted in buffer containing 10 nM okadaic acid (PP1, PP2A) or 50 mM NaF (PP2C) before the kinase assay. When using PP2C, 20 mM MgCl 2 was added to the phosphatase incubation. For reactivation experiments using AMPKK, SNF1 was dephosphorylated for 10 min using PP2A (10 U ml -1 ). Dephosphorylation was stopped by adding okadaic acid to 100 nM, and aliquots were added to reactivation assays containing 5 mM MgCl 2 , 200 M ATP in 50 mM Na Hepes, pH 7.0, 0.02 % (by mass) Brij-35. AMPKK (5 U ml -1 ) was added and the mixture incubated at 30°C. For these assays the peptide AMARAASAAALARRR was used in place of the SAMS peptide, because the AMPKK preparation contains a kinase which slowly phosphorylates the latter [31] . For reactivation experiments using endogenous SRF, SNF1 was purified to the DEAE-Sepharose step, but replacing the NaF in the elution buffer with NaCl (500 mM final concentration). Dephosphorylation was carried out as before but was stopped with 100 nM okadaic acid plus 50 mM NaF (the latter to inhibit endogenous PP2C).
